Clinical Trial

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Study acronym: MUSIC-Screen
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-10-01; most recent amendment 2026-06-03.
Status change: Not Yet Recruiting → Recruiting 2025-05-13
Trial Details
NCT Number NCT06626022
Lead Sponsor University of Alberta
Conditions Prostate Cancer Screening
Enrollment 1,284 participants
Start Date 2025-05-08
Primary Completion 2029-11-30 (estimated)
Study Completion 2029-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-04